Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants

Review (2 RCTs; n=262) found early use of erythropoietin (EPO) did not significantly reduce 'Use of one or more red blood cell transfusions' or 'number of transfusions per infant" vs late administration but did increase risk of retinopathy of prematurity (any grade).


Cochrane Database of Systematic Reviews